Category: Daily in Portfolio Management

Nov 13th, 2023 - Stocks moved lower at the beginning of the day, following a US outlook downgrade by Moody’s, from stable to negative (Mercado). The broad market index (S&P 500) slipped 0.08%, the Nasdaq also ended the day 0.22% lower, however the Dow Jones rose 0.16%. Portfolio holding Nvidia (NVDA) (0.215 units @ $467.57) added 0.59$ after it announced its most recent AI chip. The H200 chip, twice as fast as the previously unveiled H100. This is the chip that a lot of firms have been waiting on to further improve their own artificial intelligence, so this rise in share price could have been forecasted. Boeing shares (BE) climbed 4.01% following an announcement from Emirates Airlines, stating they were going ahead with a $52 billion order for 95 Boeing…

Nov 12th, 2023 - Oracle (ORCL,0.4 units) and Microsoft (MSFT) have entered into a multi-year agreement to enhance artificialintelligence (AI) services. Microsoft is leveraging Oracle Cloud Infrastructure (OCI) alongside Microsoft Azureinfrastructure for AI model inference, powering Bing's everyday conversational searches.. This collaborationenables Oracle to empower new global experiences, improving access and speed for Bing's search resultsthrough the combined use of both AI infrastructures.Novo Nordisk (NVO, 1 unit) announced the primary results of SELECT, its landmark cardiovascular outcomes trialinvestigating the effects of once weekly semaglutide 2.4 mg in adults with established cardiovascular andoverweight disease. The trial shows a groundbreaking 20% reduction in cardiovascular events over five years inoverweight adults reducing risks of heart-related events and mortality. Novo Nordisk aims for label updates in theUS and EU, with an expected 2024 decision…

Nov 11th, 2023 - This week AstraZeneca has entered into the obesity drug market by acquiring ECC5004, an experimental weight-loss pill, sparking competition with Eli Lilly and Novo Nordisk. Although AstraZeneca's move initially impacted Eli Lilly's stock negatively, the company maintains a first- mover advantage with a more sophisticated obesity pill in development. The GLP-1 drug market, known for blood sugar control and weight loss, is lucrative, and Eli Lilly's robust pipeline, including orforglipron, is highlighted. Analysts frame the competition between Eli Lilly and Novo Nordisk as a "market-creation" dynamic, possibly leading to a structural duopoly in the obesity drug market. Eli Lilly's confidence in treating Alzheimer's further enhances its positive outlook. Investors may experience short-term fluctuations in both companies' stocks due to increased competition, but long-term prospects hinge on…

Nov 10th, 2023 - Groupon shares tumbled 39.5%, a day after the company posted their third-quarter results that were not matching with analysts’ expectations. The company’s CEO also admitted that the business continues to be challenged, but he also added that he is pleased that there is an improvement in the financial performance of Groupon.   Plug Power shares lost more than 40% of their value today after third-quarter results missed analysts’ estimates. The hydrogen fuel cell developer issued a going concern notice about its potential inability to fund operations over the next year. The main reasons behind this collapse are significant difficulties for the company to the accessibility of hydrogen. Due to these factors, JPMorgan downgraded Plug Power price target.  Synaptics gained 13.7% after beating analysts’ expectations in its third-quarter…

Nov 9th, 2023 - Shares rose again today, following a stabilization in Treasury Yields. The Dow Jones climbed 1.15%, the S&P 500 instead climbed 1.56%. The tech heavy NASDAQ however added 2.05%, giving it its best day since May. Groupon shares tumbled 34.82%, a day after the company posted their third-quarter results, which didn’t match analysts’ expectations. The company’s CEO also admitted that the business continues to be challenged, but he added that he is pleased there is an improvement in the financial performance of Groupon.  Plug Power shares lost more than 40.47% of their value today after third-quarter results missed analysts’ estimates. The hydrogen fuel cell developer issued an ongoing concern notice about its potential inability to fund operations over the next year. The main reason behind this decline…